These tumor biopsies showed upregulation of p-Rad50, a marker of ATM pathway activation, after treatment with ceralasertib (Figure 2, D and E), as well as an increase in the number of γH2AX-positive cells (Figure 2, F and G). Here, RAD50 is linked to neoplasm.